Tirzepatide (60m)

$120.00

1 Unit
$120 per unit
$120.00
2 Units
$117 per unit (save 3% per unit)
$234.00
$240.00
3 Units
$114 per unit (save 5% per unit)
$342.00
$360.00
4 Units
$111 per unit (save 8% per unit)
$444.00
$480.00
5 Units
$108 per unit (save 10% per unit)
$540.00
$600.00
6 Units
$105 per unit (save 13% per unit)
$630.00
$720.00
7 Units
$102 per unit (save 15% per unit)
$714.00
$840.00
8 Units
$99 per unit (save 18% per unit)
$792.00
$960.00
9 Units
$96 per unit (save 20% per unit)
$864.00
$1,080.00
10 Units
$93 per unit (save 23% per unit)
$930.00
$1,200.00
Category:

Description

Tirzepatide is a dual-action peptide therapy that activates both GLP-1 and GIP receptors, offering significant benefits for blood sugar control and weight management in individuals with type 2 diabetes and obesity.
Clinical trials have demonstrated its ability to reduce HbA1c levels by up to 2.3% and achieve substantial weight loss, with some patients losing over 12 kg.

Improved Glycemic Control: Tirzepatide enhances insulin secretion and reduces glucagon release, leading to better regulation of blood glucose levels.
Significant Weight Loss: It promotes weight reduction by suppressing appetite, increasing satiety, and slowing gastric emptying, with clinical trials showing up to 20% body weight loss in some cases.
Enhanced Insulin Sensitivity: The peptide improves the body’s response to insulin, which is particularly beneficial for individuals with insulin resistance.
Cardiovascular Risk Reduction: Evidence suggests tirzepatide may lower cardiovascular risks, although further research is ongoing.
Convenient Dosing: Administered as a once-weekly subcutaneous injection, it offers a convenient regimen compared to daily medications.
Lower Hypoglycemia Risk: Due to its glucose-dependent mechanism, tirzepatide carries a reduced risk of causing low blood sugar compared to some other diabetes treatments.
Additional Metabolic Benefits: It may improve lipid metabolism and energy balance, contributing to overall metabolic health